Xenotransplantation - Nuffield Council on Bioethics

More documents

Recommendations

Info

Working Party on Xenografts Working Party on Xenografts Professor Albert Weale, Chairman Professor of Government at the University of Essex Ms Virginia Beardshaw is Director of Commissioning at Barnet Health Agency Dr Roger Crisp is Fellow and Tutor in Philosophy at St Anne’s College, Oxford Professor Celia Davies is Professor of Health Care at the Open University Ms Annabel Ferriman is a freelance medical journalist Professor Tim Ingold is Professor of Social Anthropology at the University of Manchester Professor John Ledingham was formerly Professor of Clinical Medicine, University of Oxford, John Radcliffe Hospital Professor David Morton is a veterinary surgeon and Professor of Biomedical Science and Biomedical Ethics at the University of Birmingham Dr Brian Newbould is a member of the <strong>Nuffield</strong> <strong>Council</strong> on Bioethics and was formerly Director of International Research Affairs, ICI Corporate Research and Technology Professor Mark Walport is a Professor of Medicine at the Royal Postgraduate Medical School, Hammersmith Hospital, London Secretariat Dr Rachel Bartlett Mrs Jill Batty Mr David Shapiro vi
Terms of reference Working Party on Xenografts Terms of Reference 1 To review recent and prospective advances in xenografts and the current and prospective applications of such procedures. For these purposes xenografts are defined as the transplantation of animal cells, tissues or organs into human beings. 2 To identify and consider the ethical issues arising from current and prospective uses of xenografts, including in particular: a b c d e the ethical aspects of the case for xenografts in the light of alternative procedures or practices, taking into account current and potential benefits and current and potential difficulties; the use of animals as sources of cells, tissues or organs; the special care and maintenance of the animals intended for that use; the ethical implications of transferring human genes into animals to allow the subsequent transplantation of animal cells, tissues or organs into human beings, any other ethical issues arising from experimentation with transgenic animals to enable their use as sources of xenografts - taking account, in particular, of the possibilities of the transmission of disease across species boundaries. vii
Page 1 and 2: NUFFIELD COUNCIL ON BIOETHICS Anima
Page 3: NUFFIELD COUNCIL ON BIOETHICS Anima
Page 6 and 7: Preface Preface Since the N
Page 8 and 9: Table of contents Table of contents
Page 12 and 13: Summary of recommendations Summary
Page 14 and 15: Summary of recommendations Effects
Page 17 and 18: The promise and the problems Chapte
Page 19 and 20: The promise and the problems treatm
Page 21 and 22: The promise and the problems 1.9 It
Page 23 and 24: The promise and the problems Nevert
Page 25 and 26: The promise and the problems 1.24 T
Page 27 and 28: The promise and the problems whe
Page 29 and 30: Alternatives to xenotransplantation
Page 41 and 42: Xenotransplantation</strong
Page 53 and 54: Animal concerns : principles Chapte
Page 55 and 56: Animal concerns : principles Party
Page 57 and 58: Animal concerns : principles Specie
Page 59 and 60: Animal concerns : principles Attitu
Page 61 and 62:
Animal concerns : principles religi
Page 63 and 64:
Animal concerns : principles Figure
Page 65 and 66:
Animal concerns : principles Conser
Page 67 and 68:
Animal concerns : principles must b
Page 69 and 70:
Animal concerns : principles that d
Page 71 and 72:
Animal concerns : principles 4.50 C
Page 73 and 74:
Animal concerns : practice Chapter
Page 75 and 76:
Animal concerns : practice 5.5 Any
Page 77 and 78:
Animal concerns : practice genetic
Page 79 and 80:
Animal concerns : practice 5.16 The
Page 81 and 82:
Animal concerns : practice 5.24 Som
Page 83 and 84:
Transmission of infectious diseases
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Early patients Chapter 7 Early pati
Page 101 and 102:
Early patients to clinical trials.
Page 103 and 104:
Early patients Consent consideratio
Page 105 and 106:
Early patients outcomes associated
Page 107 and 108:
Early patients lawful “if it is i
Page 109 and 110:
Early patients increase, in the ear
Page 111 and 112:
Effects on the health care system C
Page 113 and 114:
Effects on the health care system r
Page 115 and 116:
Effects on the health care system 8
Page 117 and 118:
Personal and social effects of xeno
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125:
Conclusions and recommendations
Page 128 and 129:
Animal-to-Human Transplants : the e
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Page 164 and 165:
Page 168:
Nuffield C
show all

Xenotransplantation - Nuffield Council on Bioethics

Create successful ePaper yourself

Delete template?

Save as template?